Delivery Order SPE2DB22D1202-SPE2DB25FVKV7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,390.69 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination pharmaceutical product used in respiratory disease treatment. This firm fixed-price, non-set-aside delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order,...
- The Defense Logistics Agency awarded a delivery order valued at $63,304.11 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication delivered in a 60-dose package. The contract, issued on September 11, 2025, with completion targeted for September 12, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $8,959.25 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded on a competitive basis without set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,099.73 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $7,937.65 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with a completion date of August 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,656.74 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 (60-count units), a combination respiratory medication used to treat chronic obstructive pulmonary disease. The award, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this pharmaceutical distributor. The place of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,422.72 for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,807.35 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler format. Awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, this firm fixed price contract represents a non-set-aside competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,930.97 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product for respiratory treatment. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this competitively awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,076.77 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count supply). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 22, 2025. The award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters location, which also serves as the place of performance for...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKV7Delivery Order
The Defense Logistics Agency (DLA) awarded a $69,245.28 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of September 10, 2025. The award represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates consistent capability to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Performance of this delivery order will occur at the contractor's Conshohocken facility, supporting the military healthcare supply chain's ongoing pharmaceutical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $69.2k | 9/9/25 |